68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 WP Fendler, M Eiber, M Beheshti, J Bomanji, F Ceci, S Cho, F Giesel, ... European journal of nuclear medicine and molecular imaging 44, 1014-1024, 2017 | 769 | 2017 |
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging … J Calais, F Ceci, M Eiber, TA Hope, MS Hofman, C Rischpler, ... The Lancet Oncology 20 (9), 1286-1294, 2019 | 385 | 2019 |
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? F Ceci, C Uprimny, B Nilica, L Geraldo, D Kendler, A Kroiss, J Bektic, ... European journal of nuclear medicine and molecular imaging 42, 1284-1294, 2015 | 312 | 2015 |
68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact on salvage … J Calais, J Czernin, M Cao, AU Kishan, JV Hegde, N Shaverdian, ... Journal of Nuclear Medicine 59 (2), 230-237, 2018 | 273 | 2018 |
E-PSMA: the EANM standardized reporting guidelines v1. 0 for PSMA-PET F Ceci, DE Oprea-Lager, L Emmett, JA Adam, J Bomanji, J Czernin, ... European journal of nuclear medicine and molecular imaging 48, 1626-1638, 2021 | 248 | 2021 |
Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 … TA Hope, M Eiber, WR Armstrong, R Juarez, V Murthy, C Lawhn-Heath, ... JAMA oncology 7 (11), 1635-1642, 2021 | 204 | 2021 |
Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-choline PET/CT scan before salvage radiation therapy? P Castellucci, F Ceci, T Graziani, R Schiavina, E Brunocilla, R Mazzarotto, ... Journal of Nuclear Medicine 55 (9), 1424-1429, 2014 | 153 | 2014 |
68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment … A Farolfi, F Ceci, P Castellucci, T Graziani, G Siepe, A Lambertini, ... European journal of nuclear medicine and molecular imaging 46, 11-19, 2019 | 133 | 2019 |
Global attitudes in the management of acute appendicitis during COVID‐19 pandemic: ACIE Appy Study B Ielpo, M Podda, G Pellino, F Pata, R Caruso, G Gravante, S Di Saverio, ... British Journal of Surgery 108 (6), 717-726, 2021 | 121 | 2021 |
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial F Ceci, K Herrmann, P Castellucci, T Graziani, C Bluemel, R Schiavina, ... European journal of nuclear medicine and molecular imaging 41, 2222-2231, 2014 | 111 | 2014 |
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions S Fanti, S Minozzi, JJ Morigi, F Giesel, F Ceci, C Uprimny, MS Hofman, ... European journal of nuclear medicine and molecular imaging 44, 1622-1635, 2017 | 109 | 2017 |
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0 WP Fendler, M Eiber, M Beheshti, J Bomanji, J Calais, F Ceci, SY Cho, ... European journal of nuclear medicine and molecular imaging 50 (5), 1466-1486, 2023 | 108 | 2023 |
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy F Ceci, P Castellucci, T Graziani, A Farolfi, C Fonti, F Lodi, S Fanti European Journal of Nuclear Medicine and Molecular Imaging 46, 31-39, 2019 | 102 | 2019 |
Comparison of 68Ga-PSMA-11 and 18F-fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence J Calais, WP Fendler, K Herrmann, M Eiber, F Ceci Journal of Nuclear Medicine 59 (5), 789-794, 2018 | 94 | 2018 |
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series T Graziani, F Ceci, P Castellucci, G Polverari, GM Lima, F Lodi, ... European journal of nuclear medicine and molecular imaging 43, 1971-1979, 2016 | 91 | 2016 |
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel F Ceci, P Castellucci, T Graziani, R Schiavina, R Renzi, M Borghesi, ... European journal of nuclear medicine and molecular imaging 43, 84-91, 2016 | 90 | 2016 |
18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival G Polverari, F Ceci, V Bertaglia, ML Reale, O Rampado, E Gallio, ... Cancers 12 (5), 1163, 2020 | 87 | 2020 |
11C-Choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT F Ceci, P Castellucci, T Graziani, R Schiavina, E Brunocilla, R Mazzarotto, ... European journal of nuclear medicine and molecular imaging 41, 878-886, 2014 | 82 | 2014 |
Potential impact of 68Ga-PSMA-11 PET/CT on the planning of definitive radiation therapy for prostate cancer J Calais, AU Kishan, M Cao, WP Fendler, M Eiber, K Herrmann, F Ceci, ... Journal of Nuclear Medicine 59 (11), 1714-1721, 2018 | 79 | 2018 |
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level< 0.5 ng/mL M Mamede, F Ceci, P Castellucci, R Schiavina, C Fuccio, C Nanni, ... Clinical nuclear medicine 38 (9), e342-e345, 2013 | 76 | 2013 |